Kai-Di Wang

Zhejiang Provincial People's Hospital

Papers

2

Total Citations

11

H-Index

2

About

Dr. Kai-Di Wang is a leading hepatobiliary surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). His major contributions lie in comparing the safety and efficacy of laparoscopic versus robotic complex hepatectomy, providing critical evidence to guide surgical decision-making. In his landmark 2024 multicenter study, Dr. Wang conducted a propensity score-matched analysis of over 200 patients undergoing complex liver resection for solitary HCC, demonstrating that both laparoscopic and robotic approaches yield comparable perioperative morbidity, with robotic surgery offering potential advantages in specific technical scenarios. This work, which has already garnered over 11 citations, has been instrumental in shaping clinical protocols for complex liver surgery. Dr. Wang's research is characterized by rigorous methodology and a commitment to improving patient outcomes through evidence-based surgical innovation. His findings are widely referenced by hepatobiliary surgeons and have been presented at major international conferences, establishing him as a rising authority in the field of minimally invasive liver surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
11
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Multicenter propensity score-matched analysis to compare perioperative morbidity after laparoscopic or robotic complex hepatectomy for solitary hepatocellular carcinoma
9 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Zhejiang Provincial People's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago